Answers are grounded in this paper and cite their sources.
This preliminary evidence suggests a potential contribution of BRCA1 5382insC mutation to breast cancer development in Uzbek population. Taking into account a high disease penetrance in carriers of BRCA1 mutation, it seems reasonable to recommend inclusion of the 5382insC mutation test in future research on the development of screening programs for breast cancer prevention in Uzbekistan.
No takes yet. Share an insight, caveat, or question.
Abdikhakimov et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: